Published: 15 February 2022

Committees

SUMMARY OF RECOMMENDATIONS FROM THE 114TH MEETING OF THE MEDICINES ASSESSMENT ADVISORY COMMITTEE HELD IN WELLINGTON ON TUESDAY 1 February 2022

4.

Applications for consent to distribute a new medicine under section 23 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2))

4.1

Nuvaxovid (Novavax SARS-CoV-2 rS Vaccine with Matrix-M1 Adjuvant), 10µg/mL, solution for injection
(Biocelect New Zealand Ltd)

The Committee recommended that the delegate of the Minister of Health should grant provisional consent to the distribution of these medicines under Section 23 of the Medicines Act 1981 with the conditions proposed by Medsafe. The Committee agreed to Medsafe’s proposal that the provisional consent should have an effect of nine months.
Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /